Berry Genomics Co.,Ltd (SHE:000710)
China · Delayed Price · Currency is CNY 10.54
-0.06 (-0.57%)
May 19, 2026, 10:35 AM CST
Berry Genomics Co.,Ltd Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | -209.57 | -196.29 | -192.43 | -427.2 | -248.93 | -110.82 |
Depreciation & Amortization | 89.03 | 89.03 | 91.05 | 113.94 | 102.72 | 106.4 |
Other Amortization | 13.6 | 13.6 | 9.31 | 8.91 | 12.56 | 13.83 |
Loss (Gain) From Sale of Assets | -5 | -5 | -1.74 | 0.01 | 0.35 | -0.26 |
Asset Writedown & Restructuring Costs | 2.41 | 2.41 | 0.66 | 159.38 | 0.07 | 5.16 |
Loss (Gain) From Sale of Investments | 3.54 | 3.54 | 40.16 | 82.67 | 144.31 | 49.13 |
Provision & Write-off of Bad Debts | - | - | 130.68 | 162.77 | 98 | 53.6 |
Other Operating Activities | 74.63 | 118.39 | 19.35 | 21.47 | 5.54 | 31.98 |
Change in Accounts Receivable | 63.2 | 63.2 | -16.69 | 83.22 | -24.6 | -134.88 |
Change in Inventory | 18.83 | 18.83 | 31.95 | 0.89 | 6.85 | -57.53 |
Change in Accounts Payable | -29.68 | -29.68 | -30.3 | -38.2 | -88.03 | 152.02 |
Change in Other Net Operating Assets | -2.1 | -2.1 | 0.63 | -11.26 | 50.74 | 22.42 |
Operating Cash Flow | 13.57 | 70.61 | 87.97 | 111.01 | 21.18 | 94.03 |
Operating Cash Flow Growth | -85.88% | -19.74% | -20.75% | 424.14% | -77.48% | -41.71% |
Capital Expenditures | -76.52 | -75.68 | -56.75 | -55.1 | -73.31 | -336.69 |
Sale of Property, Plant & Equipment | 15.95 | 12.07 | 421.04 | 0.13 | 0.09 | 0.43 |
Divestitures | - | - | - | - | 1.71 | - |
Investment in Securities | -6.26 | -2.13 | -171.5 | 0.6 | 20.22 | -11.21 |
Other Investing Activities | - | - | -2.36 | 7 | 1.87 | - |
Investing Cash Flow | -66.83 | -65.74 | 190.43 | -47.37 | -49.42 | -347.47 |
Long-Term Debt Issued | - | 182.85 | 123.3 | 212.43 | 286.27 | 207.87 |
Total Debt Issued | 262.2 | 182.85 | 123.3 | 212.43 | 286.27 | 207.87 |
Long-Term Debt Repaid | - | -141.98 | -353.54 | -264.22 | -339.28 | -199.05 |
Total Debt Repaid | -232.2 | -141.98 | -353.54 | -264.22 | -339.28 | -199.05 |
Net Debt Issued (Repaid) | 30 | 40.87 | -230.24 | -51.79 | -53.01 | 8.82 |
Issuance of Common Stock | 30 | - | - | - | - | 56.46 |
Common Dividends Paid | -4.95 | -4.73 | -8.69 | -15.5 | -28.29 | -9.59 |
Other Financing Activities | -24.09 | -24.09 | 1.09 | - | - | -10.85 |
Financing Cash Flow | 30.96 | 12.06 | -237.85 | -67.29 | -81.3 | 44.84 |
Foreign Exchange Rate Adjustments | -4.75 | -3.03 | 1.63 | 1.5 | 11.19 | -2.67 |
Net Cash Flow | -27.05 | 13.89 | 42.18 | -2.15 | -98.35 | -211.27 |
Free Cash Flow | -62.95 | -5.08 | 31.22 | 55.91 | -52.13 | -242.66 |
Free Cash Flow Growth | - | - | -44.16% | - | - | - |
Free Cash Flow Margin | -6.83% | -0.55% | 2.90% | 4.86% | -3.81% | -17.06% |
Free Cash Flow Per Share | -0.18 | -0.01 | 0.09 | 0.16 | -0.17 | -0.68 |
Cash Income Tax Paid | 46.49 | 46.49 | 63.58 | 46.39 | -3.27 | 71.81 |
Levered Free Cash Flow | 107.42 | - | 16.38 | 206.97 | 18.73 | -210.42 |
Unlevered Free Cash Flow | 108.32 | - | 22.52 | 217.19 | 29.75 | -197.73 |
Change in Working Capital | 44.93 | 44.93 | -9.07 | -10.95 | -93.45 | -54.99 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.